YIDA CHINA (03639) The contracted sales amount for the fiscal year 2024 is approximately RMB 947 million, a year-on-year decrease of 31.6%.
Yida China (03639) announced that in December 2024, the group's contract sales amount will be approximately RMB 0...
YIDA CHINA (03639) announced that in December 2024, the group's contract sales amounted to approximately RMB 60 million and the group's equity contract sales amounted to approximately RMB 57 million. During the same period, the group's sales area was 5,109 square meters and the equity sales area was 4,851 square meters. The group's average selling price was approximately RMB 11,707 per square meter and the equity average selling price was approximately RMB 11,676 per square meter.
For the 12 months ending December 31, 2024, the group's contract sales amounted to approximately RMB 947 million, a 31.6% decrease compared to the previous year; and the group's equity contract sales amounted to approximately RMB 914 million. During the same period, the group's sales area was 76,800 square meters and the equity sales area was 71,300 square meters. The group's average selling price was approximately RMB 12,333 per square meter and the equity average selling price was approximately RMB 12,824 per square meter.
Related Articles

US Stock Market Move | Microsoft Corporation is in talks with Broadcom Inc. for a custom chip collaboration. Marvell Technology, Inc. (MRVL.US) plunges nearly 10%.

US Stock Market Move | Subsidiary 4Divinity receives $3 million strategic investment from GCL Global (GCL.US), with shares rising nearly 10% at the opening bell.

US Stock Market Move | Flagship drug achieves major breakthrough, Kymera Therapeutics (KYMR.US) surges over 40%
US Stock Market Move | Microsoft Corporation is in talks with Broadcom Inc. for a custom chip collaboration. Marvell Technology, Inc. (MRVL.US) plunges nearly 10%.

US Stock Market Move | Subsidiary 4Divinity receives $3 million strategic investment from GCL Global (GCL.US), with shares rising nearly 10% at the opening bell.

US Stock Market Move | Flagship drug achieves major breakthrough, Kymera Therapeutics (KYMR.US) surges over 40%

RECOMMEND

Baidu’s AI Ace Kunlunxin Prepares For Hong Kong IPO, Domestic Computing Power Faces Crucial Test
08/12/2025

Institutions Say Short-Term Volatility Does Not Alter Upward Trend Of Hong Kong Stocks, Hang Seng Index Still Expected To Challenge 30,000 Points Next Year
08/12/2025

As The 2025 Central Economic Work Conference Approaches, What New Expectations Lie Ahead For Next Year’s Economic Agenda? Institutions Forecast Five Key Highlights
08/12/2025


